Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | -1.00% | +8.74% | +0.51% |
Financials (USD)
Sales 2024 * | 23.11M | Sales 2025 * | 18.17M | Capitalization | 163M |
---|---|---|---|---|---|
Net income 2024 * | -37M | Net income 2025 * | -33M | EV / Sales 2024 * | 7.03 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.94 x |
P/E ratio 2024 * |
-4.61
x | P/E ratio 2025 * |
-4.46
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.34% |
Latest transcript on ProQR Therapeutics N.V.
1 day | -1.00% | ||
1 week | +8.74% | ||
Current month | +2.05% | ||
1 month | -1.49% | ||
3 months | +5.29% | ||
6 months | -0.50% | ||
Current year | +0.51% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel de Boer
FOU | Founder | 41 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Jurriaan Dekkers
DFI | Director of Finance/CFO | - | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Domenico Valerio
FOU | Founder | 67 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Alison Lawton
BRD | Director/Board Member | 62 | 14-09-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 1.99 | -1.00% | 73,785 |
24-06-05 | 2.01 | +0.50% | 34,311 |
24-06-04 | 2 | +1.01% | 128,642 |
24-06-03 | 1.98 | +1.54% | 68,397 |
24-05-31 | 1.95 | +6.56% | 64,672 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.51% | 163M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.64% | 22.82B | |
-10.35% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- PRQR Stock